| |
| |
|
| Insider
Information: |
Parini Michael |
| Relationship: |
EVP, Chief Adm, Leg & ... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
30,837 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,895,504 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,837 |
|
|
| Total
Value |
$14,895,504 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Adm, Leg & ... |
2021-02-25 |
30,837 |
2016-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-04-16 |
4 |
OE |
$90.29 |
$712,279 |
D/D |
6,375 |
37,128 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-05-03 |
4 |
AS |
$170.33 |
$279,074 |
D/D |
(1,622) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-05-03 |
4 |
OE |
$86.52 |
$201,505 |
D/D |
2,329 |
37,332 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-05-15 |
4 |
AS |
$165.41 |
$13,729 |
D/D |
(83) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-05-30 |
4 |
AS |
$173.00 |
$122,311 |
D/D |
(707) |
35,625 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-07-05 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
39,253 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-07-05 |
4 |
AS |
$178.01 |
$761,239 |
D/D |
(4,250) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-07-12 |
4 |
AS |
$175.09 |
$372,455 |
D/D |
(2,125) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-07-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
37,128 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-08-05 |
4 |
AS |
$174.74 |
$408,399 |
D/D |
(2,330) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-08-05 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
37,333 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-10-14 |
4 |
AS |
$173.44 |
$369,885 |
D/D |
(2,125) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-10-14 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
37,128 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-10-17 |
4 |
AS |
$177.80 |
$755,650 |
D/D |
(4,250) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-10-17 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
39,253 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-11-04 |
4 |
AS |
$200.20 |
$467,168 |
D/D |
(2,330) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-11-04 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
37,333 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-11-15 |
4 |
AS |
$205.95 |
$17,300 |
D/D |
(84) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-06 |
4 |
AS |
$218.93 |
$943,514 |
D/D |
(4,250) |
35,003 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-06 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
39,253 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-22 |
4 |
AS |
$237.50 |
$238 |
D/D |
(1) |
35,003 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-22 |
4 |
OE |
$187.53 |
$188 |
D/D |
1 |
35,004 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-31 |
4 |
D |
$231.21 |
$310,746 |
D/D |
(1,344) |
33,659 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-31 |
4 |
AS |
$238.65 |
$932,883 |
D/D |
(3,909) |
35,003 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-31 |
4 |
OE |
$187.53 |
$733,055 |
D/D |
3,909 |
38,912 |
0 |
- |
|
115 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
